Description
CV-65 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity, inhibiting activation of JNK and ERK5 and suppressing proliferation in various tumor cell lines.
CV-65 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity, inhibiting activation of JNK and ERK5 and suppressing proliferation in various tumor cell lines.
| Purity | ≥70% |
|---|---|
| Formula | C14H10N2O4 |
| Formula Wt. | 270.24 |
| Chemical Name | 3,6-Dimethyl-1,8-diazaanthracene-2,7,9,10(1H,8H)-tetrone |
| IUPAC Name | 3,7-dimethyl-1,9-dihydropyrido[3,2-g]quinoline-2,5,8,10-tetrone |
| Appearance | Orange Solid |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
S-isomer of omeprazole; H+/K+ ATPase inhibitor....
Mycotoxin produced by Alternaria; topoisomerase...
Alkaloid compound originally found in Corydalis...
Synthetic ITC.
T-type Ca2+ and voltage-gated Na+ channel block...
NSAID; COX-1/2 inhibitor.
Androgen receptor downregulator.
ATP-sensitive K+ channel activator, α-adrenerg...
Synthetic nitrile compound
Sulforaphane-cysteine conjugate.
Endogenous neuropeptide, involved in nociceptio...
PKC and S6 kinase substrate.
Protein translation inhibitor.
TxA2 synthase inhibitor.
D2/3 agonist.
AMPK activator.
Fluoroquinolone; topoisomerase IV, topoisomeras...
Glutamine analog; γ-glutamyl transferase, CTP ...
Oxazoline; glucocorticoid agonist.
Recombinant HCV antigen fragment.